Glaucoma is a leading cause of preventable and irreversible blindness. [1] [2] [3] [4] [5] Glaucoma is a chronic and progressive neurodegenerative disorder causing loss of retinal ganglion cells and their axons. Characteristic 'cupping' of the optic disc is seen with corresponding loss of visual field. Elevated intraocular pressure (IOP) is a causative risk factor for the development and progression of glaucoma, and lowering IOP is the mainstay of treatment. Besides IOP, other risk factors are well-known, e.g. age, family history, and race (e.g. African descent).
Goniotomy
Goniotomy is used to enhance the route for aqueous humor outflow into Schlemm's canal. For this purpose, the tissue of the chamber angle is incised under direct visualization with an operating microscope and a surgical gonioscopy lens or with a fiber optic probe. 45 Instead of a surgical knife, a photoablative laser device can be used. 46, 47 In 1997,
Medow and Sauer reported the first use of endoscopic goniotomy in human subjects. 48 Goniotomy is known as the gold standard for the treatment of primary congenital (infantile) glaucoma. A successful goniotomy improves the aqueous outflow and IOP control can be maintained for extended periods of time. 49 For the procedure, an incision just below the Schwalbe line is made to open Schlemm's canal.
Early treatment is important, as the success rate of goniotomy is dependent on the patient's age. From those patients who had glaucomatous anomalies at birth or older than two years and who underwent one or two goniotomies, about 26 % were controlled. 50, 51 However, in patients between one and 24 months of age the success rate is 90-94 %. 55, 56 In addition, the rate of post-operative complications is low.
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Excimer Laser Trabeculotomy
ELT ab interno is a minimally invasive surgical technique to reduce IOP in patients with glaucoma or ocular hypertension by creating pores from the anterior chamber into Schlemm's canal. [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] There are almost no thermal side effects or damage to the outer wall of Schlemm's canal.
The punctual ablation of TM by an excimer laser was first described in 1996 by Vogel et al. 68 They used a prototype laser and the application was monitored using a contact lens. The ELT technique differs from that of other minimally invasive glaucoma laser techniques like argon laser trabeculotomy (ALT) or selected laser trabeculotomy (SLT). The latter ones induce tissue alterations by heat or tissue remodeling, respectively. Therefore, the effects of ALT and SLT reduce over time.
After ELT, the edges of the openings are found to be very smooth. 68, 71 This should minimize wound healing, and thus contribute to a long-lasting IOP reduction.
If filtering surgery is required following ELT, the outcome is not compromised by ELT. As there is no conjunctival touch during ELT, no conjunctival scarring that would influence the outcome of TE is expected.
It is known that phacoemulsification in isolation results in reduced IOP. [73] [74] [75] [76] [77] The IOP reduction of combined phaco and ELT (phaco-ELT) is greater than that of either cataract surgery or ELT alone. 65, 72 One likely explanation is the deepening of the anterior chamber angle by extraction of the thickened cataractous lens.
ELT could easily be performed at the end of a clear cornea phacoemulsification or as a stand-alone procedure. It can reduce IOP for an extended period of time and is associated with a low rate of complications. 65, 72, 78 The duration of cataract surgery is only prolonged by 2-3 minutes for the ELT. The same corneal incision as for phacoemulsification is used.
In our procedure, at the end of the cataract surgery or at the beginning of a stand-alone procedure, a medical miosis is performed with acetylcholine chloride and the anterior chamber deepened with
viscoelastics. An endoscopically guided photoablative laser (see Figure  1) operating at a wavelength of 308 nm (excimer laser, AIDA, TUI-Laser, Munich, Germany) is used to create ten microperforations into the TM spread over an area of 90°. Each microperforation is about 0.5 mm in diameter (diameter of the laser fiber). Further details of the device are given in Table 1 . To transmit the complete energy of the laser to the TM,
Figure 1: Surgical Microscope Image of the Laser Fiber and Endoscopic Optics used in Excimer Laser Trabeculotomy
The laser fiber tip overlaps the optics by approximately 3 mm. the laser tip must make contact with the tissue (see Figure 2) . After laser application, a formation of bubbles can be seen together with a small retrograde bleeding. This indicates the perforation of the TM and the inner wall of Schlemm's canal (see Figure 3) . Bleeding stops spontaneously almost immediately. At the end of the surgical procedure, the viscoelastics are removed with aspiration and irrigation and the globe is pressurized to approximately 15 mmHg.
We conducted a preliminary study that included 28 eyes of 28 patients with a pre-operative IOP of over 21 mmHg (mean 25.33 ± 2.85 mmHg).
One year after combined phaco-ELT we found a mean IOP reduction of Table 2 .
Conclusion
A range of surgical options to lower IOP is available. TE with antimetabolites is still the gold standard. The goal of minimizing post-operative complications demands minimally invasive procedures.
In the event of a very low target IOP, TE is the treatment of choice.
However, it may also be possible to achieve a sufficient reduction in IOP with endoscopic surgical methods. Goniotomy is mostly used in infantile glaucoma, and goniopuncture is an option following deep sclerectomy.
Excimer laser trabeculotomy could become more popular in combination with a phacoemulsification in minimally invasive endoscopic surgery, as it causes fewer complications compared to TE. For a selected cohort of glaucoma patients, in particular those with an IOP over 21 mmHg and at least moderate cataract, the combined procedure of ELT and phacoemulsification appears to be a promising approach to avoid (or at least to delay for some years) the onset of TE. n 
